首頁 > 市場調查報告書 > 醫療設備

生技設備

市場調查報告書

商品編碼

1548060

全球寡核苷酸合成市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢與預測

Global Oligonucleotide Synthesis Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年07月01日 | 出版商:

Value Market Research | 英文 123 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

預計到2032年，全球寡核苷酸合成市場的市場規模將從2023年的39.2億美元達到近129.1億美元，2024-2032年研究期間的複合年成長率為14.16%。

寡核苷酸合成是指化學合成具有確定的化學結構或各種大小的序列的核酸片段。這個過程能夠產生自然界中不存在的基因。由於基因技術的進步，實驗室合成寡核苷酸已成為現實。寡核苷酸在生物化學、分子診斷、基因組學和其他分子生物學應用等各個生物領域中受到追捧。這種合成技術的出現在很大程度上有助於癌症、肝炎和自體免疫抗體治療的進步。分子生物學的進步對癌症疫苗開發、免疫治療和早期檢測提出了很高的期望。隨著自動化能力的不斷提高，對生物體基因組的有效操作將持續提高。

市場動態

由於製藥和生物技術領域研究活動的增加，該市場出現顯著成長。對創新診斷和治療技術的需求不斷成長，以及政府用於開發基因組技術的支出增加，也可以推動市場成長。由於資源缺乏、需求有限和成本限制，市場範圍可能會縮小。缺乏在這一新興領域進行研究的熟練人員可能會阻礙該市場的成長。該報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具還對全球寡核苷酸合成市場的每個細分市場進行了包容性評估。寡核苷酸合成產業的成長和趨勢為本研究提供了整體方法。

市場區隔

寡核苷酸合成市場報告的這一部分提供了國家和區域層面細分市場的詳細資料，從而幫助策略師確定相應產品或服務的目標人口統計數據以及即將到來的機會。

按產品和服務

寡核苷酸
設備/合成器
試劑
服務

按申請

PCR引子
PCR 檢測與試劑盒
定序
DNA微陣列
螢光原位雜合技術 (FISH)
反義寡核苷酸
其他應用

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲寡核苷酸合成市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。寡核苷酸合成市場的主要參與者包括 Thermo Fisher Scientific Inc.、Merck KGaA、Danaher Corporation、Dharmacon Inc.、Agilent Technologies、Bio-Synthesis、Kaneka Eurogentec SA、LGC Biosearch Technologies、Biolegio、Twist Bioscience。本節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

區域展望
介紹
北美銷售分析
- 概覽、歷史與預測資料銷售分析
- 北美按細分市場銷售分析
- 北美按國家銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概覽、歷史與預測資料銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區按國家銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲按國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析

第 8 章：寡核苷酸合成公司的競爭格局

寡核苷酸合成市場競爭
夥伴關係/協作/協議
併購
新產品發布
其他發展

第 9 章：公司簡介

頂級公司市佔率分析
市場集中度
Thermo Fisher Scientific Inc.

公司概況
公司收入
產品
最新動態

Merck KGaA

公司概況
公司收入
產品
最新動態

Danaher Corporation

公司概況
公司收入
產品
最新動態

Dharmacon Inc.

公司概況
公司收入
產品
最新動態

Agilent Technologies

公司概況
公司收入
產品
最新動態

Bio-Synthesis

公司概況
公司收入
產品
最新動態

Kaneka Eurogentec SA

公司概況
公司收入
產品
最新動態

LGC Biosearch Technologies

公司概況
公司收入
產品
最新動態

Biolegio

公司概況
公司收入
產品
最新動態

Twist Bioscience

公司概況
公司收入
產品
最新動態

註 - 在公司概況中，財務詳細資訊和最新發展視情況而定，或對私人公司而言可能不包括在內

簡介目錄圖表

Product Code: VMR11211903

The global demand for Oligonucleotide Synthesis Market is presumed to reach the market size of nearly USD 12.91 Billion by 2032 from USD 3.92 Billion in 2023 with a CAGR of 14.16% under the study period 2024-2032.

Oligonucleotide Synthesis refers to the chemical synthesis of nucleic acid fragments with defined chemical structures or sequences in various sizes. This process is capable of producing genes which are not existent in nature. The synthesis of oligonucleotide in the laboratory has become a reality due to the advancement in gene technology. Oligonucleotides are sought after in various biological sectors like biochemistry, molecular diagnostics, genomics, and other molecular biology applications. The advent of this synthesis technique has largely helped in advancements related to the treatment of cancer, hepatitis, and autoimmune antibodies. Improvement in molecular biology has set great expectancies related to cancer vaccine development, immunotherapy, and early detection. As automation capabilities continue to rise efficient manipulation of a living organism's genome will continue to improve.

MARKET DYNAMICS

There is a significant growth in this market due to increased research activities in the pharmaceuticals and biotechnology sectors. The rising demand for innovative diagnostic and therapeutic techniques and increased government spending for the development of genomic technologies also can fuel market growth. The market scope can be narrowed down due to a lack of resources, limited requirements and cost constraints. The lack of skilled personnel to carry out research in this newly emerging area can hinder the growth of this market. The report covers Porter's Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Oligonucleotide Synthesis. The growth and trends of Oligonucleotide Synthesis industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Oligonucleotide Synthesis market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product & Service

Oligonucleotides
Equipment/Synthesizer
Reagents
Services

By Application

PCR Primers
PCR Assays & Panels
Sequencing
DNA Microarrays
Fluorescence In Situ Hybridization (FISH)
Antisense Oligonucleotides
Other Applications

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Oligonucleotide Synthesis market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Oligonucleotide Synthesis market include Thermo Fisher Scientific Inc., Merck KGaA, Danaher Corporation, Dharmacon Inc., Agilent Technologies, Bio-Synthesis, Kaneka Eurogentec S.A, LGC Biosearch Technologies, Biolegio, Twist Bioscience. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. OLIGONUCLEOTIDE SYNTHESIS - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product & Service
- 3.7.2 Market Attractiveness Analysis By Application
- 3.7.3 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET ANALYSIS BY PRODUCT & SERVICE

5.1. Overview By Product & Service
5.2. Historical and Forecast Data
5.3. Analysis By Product & Service
5.4. Oligonucleotides Historic and Forecast Sales By Regions
5.5. Equipment/Synthesizer Historic and Forecast Sales By Regions
5.6. Reagents Historic and Forecast Sales By Regions
5.7. Services Historic and Forecast Sales By Regions

6. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET ANALYSIS BY APPLICATION

6.1. Overview By Application
6.2. Historical and Forecast Data
6.3. Analysis By Application
6.4. PCR Primers Historic and Forecast Sales By Regions
6.5. PCR Assays & Panels Historic and Forecast Sales By Regions
6.6. Sequencing Historic and Forecast Sales By Regions
6.7. DNA Microarrays Historic and Forecast Sales By Regions
6.8. Fluorescence In Situ Hybridization (FISH) Historic and Forecast Sales By Regions
6.9. Antisense Oligonucleotides Historic and Forecast Sales By Regions
6.10. Other Applications Historic and Forecast Sales By Regions

7. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET ANALYSIS BY GEOGRAPHY

7.1. Regional Outlook
7.2. Introduction
7.3. North America Sales Analysis
- 7.3.1 Overview, Historic and Forecast Data Sales Analysis
- 7.3.2 North America By Segment Sales Analysis
- 7.3.3 North America By Country Sales Analysis
- 7.3.4 United States Sales Analysis
- 7.3.5 Canada Sales Analysis
- 7.3.6 Mexico Sales Analysis
7.4. Europe Sales Analysis
- 7.4.1 Overview, Historic and Forecast Data Sales Analysis
- 7.4.2 Europe By Segment Sales Analysis
- 7.4.3 Europe By Country Sales Analysis
- 7.4.4 United Kingdom Sales Analysis
- 7.4.5 France Sales Analysis
- 7.4.6 Germany Sales Analysis
- 7.4.7 Italy Sales Analysis
- 7.4.8 Russia Sales Analysis
- 7.4.9 Rest Of Europe Sales Analysis
7.5. Asia Pacific Sales Analysis
- 7.5.1 Overview, Historic and Forecast Data Sales Analysis
- 7.5.2 Asia Pacific By Segment Sales Analysis
- 7.5.3 Asia Pacific By Country Sales Analysis
- 7.5.4 China Sales Analysis
- 7.5.5 India Sales Analysis
- 7.5.6 Japan Sales Analysis
- 7.5.7 South Korea Sales Analysis
- 7.5.8 Australia Sales Analysis
- 7.5.9 South East Asia Sales Analysis
- 7.5.10 Rest Of Asia Pacific Sales Analysis
7.6. Latin America Sales Analysis
- 7.6.1 Overview, Historic and Forecast Data Sales Analysis
- 7.6.2 Latin America By Segment Sales Analysis
- 7.6.3 Latin America By Country Sales Analysis
- 7.6.4 Brazil Sales Analysis
- 7.6.5 Argentina Sales Analysis
- 7.6.6 Peru Sales Analysis
- 7.6.7 Chile Sales Analysis
- 7.6.8 Rest of Latin America Sales Analysis
7.7. Middle East & Africa Sales Analysis
- 7.7.1 Overview, Historic and Forecast Data Sales Analysis
- 7.7.2 Middle East & Africa By Segment Sales Analysis
- 7.7.3 Middle East & Africa By Country Sales Analysis
- 7.7.4 Saudi Arabia Sales Analysis
- 7.7.5 UAE Sales Analysis
- 7.7.6 Israel Sales Analysis
- 7.7.7 South Africa Sales Analysis
- 7.7.8 Rest Of Middle East And Africa Sales Analysis

8. COMPETITIVE LANDSCAPE OF THE OLIGONUCLEOTIDE SYNTHESIS COMPANIES

8.1. Oligonucleotide Synthesis Market Competition
8.2. Partnership/Collaboration/Agreement
8.3. Merger And Acquisitions
8.4. New Product Launch
8.5. Other Developments

9. COMPANY PROFILES OF OLIGONUCLEOTIDE SYNTHESIS INDUSTRY

9.1. Top Companies Market Share Analysis
9.2. Market Concentration Rate
9.3. Thermo Fisher Scientific Inc.
- 9.3.1 Company Overview
- 9.3.2 Company Revenue
- 9.3.3 Products
- 9.3.4 Recent Developments
9.4. Merck KGaA
- 9.4.1 Company Overview
- 9.4.2 Company Revenue
- 9.4.3 Products
- 9.4.4 Recent Developments
9.5. Danaher Corporation
- 9.5.1 Company Overview
- 9.5.2 Company Revenue
- 9.5.3 Products
- 9.5.4 Recent Developments
9.6. Dharmacon Inc.
- 9.6.1 Company Overview
- 9.6.2 Company Revenue
- 9.6.3 Products
- 9.6.4 Recent Developments
9.7. Agilent Technologies
- 9.7.1 Company Overview
- 9.7.2 Company Revenue
- 9.7.3 Products
- 9.7.4 Recent Developments
9.8. Bio-Synthesis
- 9.8.1 Company Overview
- 9.8.2 Company Revenue
- 9.8.3 Products
- 9.8.4 Recent Developments
9.9. Kaneka Eurogentec S.A
- 9.9.1 Company Overview
- 9.9.2 Company Revenue
- 9.9.3 Products
- 9.9.4 Recent Developments
9.10. LGC Biosearch Technologies
- 9.10.1 Company Overview
- 9.10.2 Company Revenue
- 9.10.3 Products
- 9.10.4 Recent Developments
9.11. Biolegio
- 9.11.1 Company Overview
- 9.11.2 Company Revenue
- 9.11.3 Products
- 9.11.4 Recent Developments
9.12. Twist Bioscience
- 9.12.1 Company Overview
- 9.12.2 Company Revenue
- 9.12.3 Products
- 9.12.4 Recent Developments